What's new

Human medicines European public assessment report (EPAR): Bavencio, avelumab, Date of authorisation: 18/09/2017, Revision: 21, Status: Authorised

Human medicines European public assessment report (EPAR): Bavencio, avelumab, Date of authorisation: 18/09/2017, Revision: 21, Status: Authorised

May 7, 2025 - 11:25
 0
Human medicines European public assessment report (EPAR): Bavencio, avelumab, Date of authorisation: 18/09/2017, Revision: 21, Status: Authorised
Human medicines European public assessment report (EPAR): Bavencio, avelumab, Date of authorisation: 18/09/2017, Revision: 21, Status: Authorised
Read More

Tags:

Previous Article

Powerful collaboration! Zhengzhou Nissan and Zhongjiang International accelerate...

Next Article

‘Rocky road ahead’ for US solar, SEIA CEO warns

Related Posts

Human medicines European public assessment report (EPAR): Filspari, Sparsentan, Date of authorisation: 19/04/2024, Revision: 2, Status: Authorised

Human medicines European public assessment report (EPAR...

Apr 30, 2025  0

Human medicines European public assessment report (EPAR): Attrogy, diflunisal, Status: Opinion

Human medicines European public assessment report (EPAR...

Apr 25, 2025  0

Business process description for parallel distribution

Apr 22, 2025  0